ciclopirox has been researched along with Erythema in 4 studies
Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.
Excerpt | Relevance | Reference |
---|---|---|
" There are limited data on adverse events associated with the newer topical onychomycosis drugs." | 1.56 | Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug Administration. ( Lipner, SR; Wang, Y, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Wang, Y | 1 |
Lipner, SR | 1 |
Turchin, I | 1 |
Adams, SP | 1 |
Enta, T | 1 |
Rosen, T | 1 |
Schell, BJ | 1 |
Orengo, I | 1 |
1 trial available for ciclopirox and Erythema
Article | Year |
---|---|
Anti-inflammatory activity of antifungal preparations.
Topics: Adult; Allylamine; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Age | 1997 |
3 other studies available for ciclopirox and Erythema
Article | Year |
---|---|
Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug Administration.
Topics: Administration, Topical; Adverse Drug Reaction Reporting Systems; Antifungal Agents; Boron Compounds | 2020 |
Dermacase. Pityriasis rosea.
Topics: Acute Disease; Adolescent; Antifungal Agents; Ciclopirox; Diagnosis, Differential; Erythema; Humans; | 2004 |
Ciclopirox (Penlac) nail lacquer for onychomycosis.
Topics: Antifungal Agents; Ciclopirox; Clinical Trials as Topic; Dose-Response Relationship, Drug; Erythema; | 2000 |